Kim Seong-Jun, Ko Wan-Kyu, Han Gong-Ho, Lee Daye, Lee Yuhan, Sheen Seung-Hun, Hong Je-Beom, Sohn Seil
Department of Biomedical Science, CHA University, Seongnam-si 13493, Korea.
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Pharmaceuticals (Basel). 2021 Aug 12;14(8):792. doi: 10.3390/ph14080792.
Neuroinflammation forms a glial scar following a spinal cord injury (SCI). The injured axon cannot regenerate across the scar, suggesting permanent paraplegia. Molecular chirality can show an entirely different bio-function by means of chiral-specific interaction. In this study, we report that d-chiral glutathione (D-GSH) suppresses the inflammatory response after SCI and leads to axon regeneration of the injured spinal cord to a greater extent than l-chiral glutathione (L-GSH). After SCI, axon regrowth in D-GSH-treated rats was significantly increased compared with that in L-GSH-treated rats (*** < 0.001). Secondary damage and motor function were significantly improved in D-GSH-treated rats compared with those outcomes in L-GSH-treated rats (** < 0.01). Moreover, D-GSH significantly decreased pro-inflammatory cytokines and glial fibrillary acidic protein (GFAP) via inhibition of the mitogen-activated protein kinase (MAPK) signaling pathway compared with L-GSH (*** < 0.001). In primary cultured macrophages, we found that D-GSH undergoes more intracellular interaction with activated macrophages than L-GSH (*** < 0.001). These findings reveal a potential new regenerative function of chiral GSH in SCI and suggest that chiral GSH has therapeutic potential as a treatment of other diseases.
神经炎症在脊髓损伤(SCI)后形成胶质瘢痕。受损的轴突无法穿过瘢痕再生,这意味着会导致永久性截瘫。分子手性可以通过手性特异性相互作用表现出完全不同的生物功能。在本研究中,我们报告d-手性谷胱甘肽(D-GSH)抑制SCI后的炎症反应,并比l-手性谷胱甘肽(L-GSH)在更大程度上促进受损脊髓的轴突再生。SCI后,与L-GSH处理的大鼠相比,D-GSH处理的大鼠轴突再生显著增加(***P<0.001)。与L-GSH处理的大鼠相比,D-GSH处理的大鼠继发性损伤和运动功能得到显著改善(**P<0.01)。此外,与L-GSH相比,D-GSH通过抑制丝裂原活化蛋白激酶(MAPK)信号通路显著降低促炎细胞因子和胶质纤维酸性蛋白(GFAP)(***P<0.001)。在原代培养的巨噬细胞中,我们发现D-GSH比L-GSH与活化巨噬细胞发生更多的细胞内相互作用(***P<0.001)。这些发现揭示了手性谷胱甘肽在SCI中的潜在新再生功能,并表明手性谷胱甘肽作为治疗其他疾病具有治疗潜力。